resmetirom
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis
The FDA has approved semaglutide in conjunction with diet and exercise for the treatment of MASH with moderate to ...
AUGUST 20, 2025
Resmetirom With Weight Loss Improves MASH, Fibrosis
Patients with MASH fibrosis taking resmetirom who lost at least 5% of their body weight had a higher rate of ...
MARCH 7, 2025
Key Conference Highlights and Publications for APPs
From groundbreaking clinical trials to comprehensive educational opportunities at major conferences, APPs ...
FEBRUARY 20, 2025
New Analyses Evaluate Resmetirom’s Effects on MASH and Fibrosis
Patients with MASH and F2 or F3 fibrosis treated with resmetirom had improvements in both fibrosis and MASH over 52 ...
JANUARY 13, 2025
Expert Picks From EASL 2024
Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.
OCTOBER 30, 2024
MASH Therapy Pipeline Growing, With a Mix of Results
After years without drug treatments for metabolic dysfunction–associated steatohepatitis, recently data have ...
AUGUST 22, 2024
FDA Approves Resmetirom, First Drug for MASH
The FDA granted accelerated approval to the first medication for the treatment of MASH, resmetirom (Rezdiffra, ...
MARCH 15, 2024
Expert Picks From The Liver Meeting, Part 2
In this second installment of “Expert Picks” from The Liver Meeting 2022, Ashwani K. Singal, MD, MS, ...
APRIL 19, 2023
